Clinical Trial

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

Study acronym: READY-BREATHE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).
Trial Details
NCT Number NCT07746687
Lead Sponsor Janssen Research & Development, LLC
Conditions Asthma
Enrollment 440 participants
Start Date 2026-09-23
Primary Completion 2029-09-11 (estimated)
Study Completion 2030-07-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-05